Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 24252781.
- Also identified by DOI 10.1016/j.jpeds.2013.10.008 and PMC identifier 4699435.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among 2012 Docstyle survey respondents, 80% identified doxycycline as the appropriate treatment for Rocky Mountain spotted fever in patients ≥ 8 years old, but only 35% correctly chose doxycycline in patients <8 years old. These findings raise concerns about the higher pediatric case-fatality rate of Rocky Mountain spotted fever observed nationally. Targeted education efforts are needed.
Medical subject headings
- Anti-Bacterial Agents
- Doxycycline
- Health Knowledge, Attitudes, Practice
- Health Personnel
- Rocky Mountain Spotted Fever
- Self Report